More Evidence of Hormone Therapy, Breast Cancer Link
Posted on: Monday, 9 February 2009, 09:18 CST
New evidence has surfaced that further establishes the link between combined hormone therapy and a higher likelihood of breast cancer.
In a new study published in the New England Journal of Medicine, researchers found the number of women with breast cancer dropped significantly after they stopped using estrogen plus progestin. Furthermore, this drop was not associated with a decline in the number of women getting mammograms -- a theory some have put forward to explain the lower rate of cancer.
The Women's Health Initiative (WHI) trial of estrogen plus progestin was terminated in 2002 because of the discovery of a higher incidence of breast cancer in the hormone therapy group. After a report on the study was made public, women across the United States stopped using the therapy. Following this, the incidence of breast cancer declined nationwide.
To help explain why, researchers in the NEJM study analyzed the results of the WHI trial to look for trends in breast cancer diagnoses. They found the number of cases of breast cancer was about two times higher in the group taking the therapy than in the control group, but after participants discontinued the therapy, that risk quickly declined. The results also suggest that termination of combined hormone therapy may put preclinical breast cancers into regression.
Although some experts have suggested the widespread drop in cancer incidence after the study may be explained by a decrease in mammograms, the new study results damage that theory. While the number of women who received mammograms every year remained the same after they left the study, the number of breast cancer cases in the group that had received the hormone therapy declined significantly.
SOURCE: New England Journal of Medicine, 2009;360:573-587
---
On the Net:
Source: Ivanhoe
Related Articles
- Mother-Daughter Breast Density Study Points Way To Earlier Cancer Risk Assessment
- Risk of Breast Cancer Mutations Underestimated for Asian Women, Stanford Study Shows
- Tracon Initiates Dosing in Phase I Cancer Combination Therapy Study
- Studies Tie Hormones, Cancer Risk: Therapy Still Right for Some, Doctors Say
- New Analysis of Data From WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
- St. Louis Cancer & Breast Institute Physician Says Hormone Replacement Therapy Does Indeed Create Breast Cancer Risk
- Femara(R) Receives US Approval As Initial Therapy for Postmenopausal Women With Early Breast Cancer After Surgery
- Women Warned Hormone Therapy Can Increase Risk of Womb Cancer
- Study Published in the New England Journal of Medicine Could Leave Asthma Patients Gasping for Air
- Breast Cancer Most Common Among Vietnamese Women
 |
 |
User Comments (0)
RSS Feeds